Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
177.26M | 341.80M | 448.65M | 485.79M | 413.30M | Gross Profit |
28.00M | 44.93M | 54.44M | 71.59M | 64.64M | EBIT |
-23.81M | -26.39M | -36.53M | -14.56M | -21.36M | EBITDA |
-59.61M | -50.01M | -75.13M | -7.62M | -39.65M | Net Income Common Stockholders |
-73.94M | -72.32M | -94.37M | -35.63M | -87.66M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
78.02M | 61.95M | 60.48M | 98.55M | 122.36M | Total Assets |
176.55M | 243.88M | 381.51M | 438.84M | 477.78M | Total Debt |
38.86M | 45.26M | 74.70M | 58.48M | 100.69M | Net Debt |
-18.68M | -16.69M | 14.22M | -20.72M | -21.67M | Total Liabilities |
120.38M | 117.41M | 182.80M | 145.76M | 166.89M | Stockholders Equity |
56.11M | 126.39M | 198.71M | 293.08M | 310.89M |
Cash Flow | Free Cash Flow | |||
23.47M | 29.42M | -48.28M | 12.08M | -39.47M | Operating Cash Flow |
23.68M | 35.10M | -42.12M | 13.41M | -38.75M | Investing Cash Flow |
-19.86M | 13.39M | 13.20M | -16.02M | 4.71M | Financing Cash Flow |
-8.23M | -47.02M | 10.21M | -40.55M | -46.26M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | HK$168.40B | 19.22 | 18.52% | 2.43% | 6.13% | 14.88% | |
72 Outperform | $940.29B | 6.67 | 5.49% | 11.71% | 37.04% | ||
70 Outperform | $126.28B | 10.40 | 27.60% | 4.06% | 18.03% | 71.00% | |
65 Neutral | $80.78B | 27.48 | 11.45% | 0.34% | 18.80% | 142.93% | |
61 Neutral | $6.92B | 11.84 | 3.00% | 3.95% | 2.60% | -21.94% | |
58 Neutral | HK$103.20M | ― | -89.34% | ― | -53.52% | -12.78% |